Early intervention for common cold


Leading pharmacist John Bell discusses the time-course of the common cold and the evidence of early intervention to stop common colds. He also unveils the dual advantage technology behind the mucoadhesive gel nasal spray of low pH and virus trapping action. This talk provides useful discussion pointers of when, how and who should use mucoadhesive

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The science behind analgesic and antitussive actions of menthol
Next World news wrapup: 12 May 2022